Targeting PI3K/AKT signaling pathway in obesity.

[1]  Xiaodi Wu,et al.  Intracellular galectin-3 is a lipopolysaccharide sensor that promotes glycolysis through mTORC1 activation , 2022, Nature communications.

[2]  Jesse M. Platt,et al.  The dynamic clustering of insulin receptor underlies its signaling and is disrupted in insulin resistance , 2022, Nature Communications.

[3]  Hae-Ock Lee,et al.  2′–5′ oligoadenylate synthetase‑like 1 (OASL1) protects against atherosclerosis by maintaining endothelial nitric oxide synthase mRNA stability , 2022, Nature Communications.

[4]  T. Fukuda,et al.  Phosphatase protector alpha4 (α4) is involved in adipocyte maintenance and mitochondrial homeostasis through regulation of insulin signaling , 2022, Nature Communications.

[5]  Yifu Qiu,et al.  The Hippo pathway links adipocyte plasticity to adipose tissue fibrosis , 2022, Nature Communications.

[6]  G. Yahubyan,et al.  Betulinic acid counteracts the lipid accumulation in Caenorhabditis elegans by modulation of nhr-49 expression. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  Chongwen Zhong,et al.  Identification of hub genes and candidate herbal treatment in obesity through integrated bioinformatic analysis and reverse network pharmacology , 2022, Scientific Reports.

[8]  Jianfei Pan,et al.  CTRP1 prevents high fat diet-induced obesity and improves glucose homeostasis in obese and STZ-induced diabetic mice , 2022, Journal of Translational Medicine.

[9]  G. Labouèbe,et al.  Lipid biosynthesis enzyme Agpat5 in AgRP-neurons is required for insulin-induced hypoglycemia sensing and glucagon secretion , 2022, Nature Communications.

[10]  Juan Zhao,et al.  Exenatide improves hepatocyte insulin resistance induced by different regional adipose tissue , 2022, Frontiers in Endocrinology.

[11]  A. Xu,et al.  Adipocyte-derived lactate is a signalling metabolite that potentiates adipose macrophage inflammation via targeting PHD2 , 2022, Nature Communications.

[12]  J. Ralston,et al.  Economic impacts of overweight and obesity: current and future estimates for 161 countries , 2022, BMJ Global Health.

[13]  A. Patapoutian,et al.  The role of somatosensory innervation of adipose tissues , 2022, Nature.

[14]  Bohan Zhang,et al.  Signaling pathways in obesity: mechanisms and therapeutic interventions , 2022, Signal Transduction and Targeted Therapy.

[15]  Naijin Zhang,et al.  RING-finger E3 ligases regulatory network in PI3K/AKT-mediated glucose metabolism , 2022, Cell Death Discovery.

[16]  Wei Huang,et al.  Transcriptomics and Network Pharmacology Reveal the Protective Effect of Chaiqin Chengqi Decoction on Obesity-Related Alcohol-Induced Acute Pancreatitis via Oxidative Stress and PI3K/Akt Signaling Pathway , 2022, Frontiers in Pharmacology.

[17]  Huan Wang,et al.  Perivascular brown adipocytes-derived kynurenic acid relaxes blood vessel via endothelium PI3K-Akt-eNOS pathway. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  V. Giguère,et al.  Insulin action and resistance are dependent on a GSK3β-FBXW7-ERRα transcriptional axis , 2022, Nature Communications.

[19]  W. Wahli,et al.  The hepatocyte insulin receptor is required to program the liver clock and rhythmic gene expression. , 2022, Cell reports.

[20]  G. Orlando,et al.  Anti-adipogenic activity of maackiain and ononin is mediated via inhibition of PPARγ in human adipocytes. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  L. Ho,et al.  Sirt3 Pharmacologically Promotes Insulin Sensitivity through PI3/AKT/mTOR and Their Downstream Pathway in Adipocytes , 2022, International journal of molecular sciences.

[22]  M. Wymann,et al.  The role of PI3Kγ in the immune system: new insights and translational implications , 2022, Nature Reviews Immunology.

[23]  Xinyi Fang,et al.  Akt: A Potential Drug Target for Metabolic Syndrome , 2022, Frontiers in Physiology.

[24]  A. B. Aliyu,et al.  Potential of Diterpenes as Antidiabetic Agents: Evidence from Clinical and Pre-Clinical Studies. , 2022, Pharmacological research.

[25]  M. Jokela,et al.  Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study , 2022, The lancet. Diabetes & endocrinology.

[26]  D. Sun-Waterhouse,et al.  Enhanced alleviation of insulin resistance via the IRS-1/Akt/FOXO1 pathway by combining quercetin and EGCG and involving miR-27a-3p and miR-96-5p. , 2022, Free radical biology & medicine.

[27]  A. Flouris,et al.  Irisin regulates thermogenesis and lipolysis in 3T3-L1 adipocytes. , 2022, Biochimica et biophysica acta. General subjects.

[28]  L. Foukas,et al.  Dominant Role of PI3K p110α over p110β in Insulin and β-Adrenergic Receptor Signalling , 2021, International journal of molecular sciences.

[29]  M. Tschöp,et al.  Anti-obesity drug discovery: advances and challenges , 2021, Nature reviews. Drug discovery.

[30]  F. Sharopov,et al.  Function of selected natural antidiabetic compounds with potential against cancer via modulation of the PI3K/AKT/mTOR cascade. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[31]  P. Zhan,et al.  Development of PI3K inhibitors: advances in clinical trials and new strategies (Review). , 2021, Pharmacological research.

[32]  F. Facchini,et al.  PIK3CA-Related Overgrowth Spectrum From Diagnosis to Targeted Therapy: A Case of CLOVES Syndrome Treated With Alpelisib , 2021, Frontiers in Pediatrics.

[33]  C. Schultz-Fademrecht,et al.  Cellular model system to dissect the isoform-selectivity of Akt inhibitors , 2021, Nature Communications.

[34]  R. Kulkarni,et al.  Differential roles of FOXO transcription factors on insulin action in brown and white adipose tissue. , 2021, The Journal of clinical investigation.

[35]  Shuang Wang,et al.  Hypoglycemic effect of astragaloside IV via modulating gut microbiota and regulating AMPK/SIRT1 and PI3K/AKT pathway. , 2021, Journal of ethnopharmacology.

[36]  M. Wabitsch,et al.  Anti-Adipogenic Effect of Alchemilla monticola is Mediated Via PI3K/AKT Signaling Inhibition in Human Adipocytes , 2021, Frontiers in Pharmacology.

[37]  L. van Gurp,et al.  Pancreatic Ppy-expressing γ-cells display mixed phenotypic traits and the adaptive plasticity to engage insulin production , 2021, Nature Communications.

[38]  M. Wabitsch,et al.  Ziziphus jujuba Mill. leaf extract restrains adipogenesis by targeting PI3K/AKT signaling pathway. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[39]  J. Szemraj,et al.  Chronic and Intermittent Hyperglycemia Modulates Expression of Key Molecules of PI3K/AKT Pathway in Differentiating Human Visceral Adipocytes , 2021, International journal of molecular sciences.

[40]  Jian-Lin Wu,et al.  Combined use of epigallocatechin-3-gallate (EGCG) and caffeine in low doses exhibits marked anti-obesity synergy through regulation of gut microbiota and bile acid metabolism. , 2021, Food & function.

[41]  Y. Qiu,et al.  Puerarin suppresses the hepatic gluconeogenesis via activation of PI3K/Akt signaling pathway in diabetic rats and HepG2 cells. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[42]  O. Issinger,et al.  Phytochemicals in cancer and their effect on the PI3K/AKT-mediated cellular signalling. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[43]  A. Klip,et al.  The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia. , 2021, Cell metabolism.

[44]  H. Ferris,et al.  The brain as an insulin-sensitive metabolic organ , 2021, Molecular metabolism.

[45]  G. King,et al.  Insulin's actions on vascular tissues: Physiological effects and pathophysiological contributions to vascular complications of diabetes , 2021, Molecular metabolism.

[46]  M. Heinrich,et al.  Alkaloids Used as Medicines: Structural Phytochemistry Meets Biodiversity—An Update and Forward Look , 2021, Molecules.

[47]  Hongjun Yang,et al.  Celastrol in Metabolic Diseases: Progress and Application Prospects. , 2021, Pharmacological research.

[48]  Jianhui Xie,et al.  Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[49]  J. Qiu,et al.  Puerarin improves hepatic glucose and lipid homeostasis in vitro and in vivo by regulating the AMPK pathway. , 2021, Food & function.

[50]  M. Diederich,et al.  Bioactivity of natural biflavonoids in metabolism-related disease and cancer therapies. , 2021, Pharmacological research.

[51]  J. Del Coso,et al.  The Impact of Decaffeinated Green Tea Extract on Fat Oxidation, Body Composition and Cardio-Metabolic Health in Overweight, Recreationally Active Individuals , 2021, Nutrients.

[52]  Ziren Su,et al.  Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[53]  R. Bauer,et al.  Natural products in drug discovery: advances and opportunities , 2021, Nature Reviews Drug Discovery.

[54]  Ziqiang Cao,et al.  Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis via activating the PI3K/Akt pathway and suppressing the FoxO1 pathway in type 2 diabetes. , 2021, Food & function.

[55]  M. White,et al.  Insulin receptor substrate 1, but not IRS2, plays a dominant role in regulating pancreatic alpha cell function in mice , 2021, The Journal of biological chemistry.

[56]  Jörg Menche,et al.  The PI3K pathway preserves metabolic health through MARCO-dependent lipid uptake by adipose tissue macrophages , 2020, Nature Metabolism.

[57]  Xianxing Jiang,et al.  AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis , 2020, Nature Communications.

[58]  Sunhong Kim,et al.  Prokineticin receptor 1 ameliorates insulin resistance in skeletal muscle , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  G. Orlando,et al.  Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases , 2020, Frontiers in Physiology.

[60]  James D. Johnson,et al.  Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance , 2020, Nature communications.

[61]  Kang Chen,et al.  Pomegranate flower extract bidirectionally regulates the proliferation, differentiation and apoptosis of 3T3-L1 cells through regulation of PPARγ expression mediated by PI3K-AKT signaling pathway. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[62]  Lai Kuan Lee,et al.  Celastrol attenuates inflammatory responses in adipose tissues and improves skeletal muscle mitochondrial functions in high fat diet-induced obese rats via upregulation of AMPK/SIRT1 signaling pathways. , 2020, European journal of pharmacology.

[63]  K. Taguchi,et al.  Plant polyphenols Morin and Quercetin rescue nitric oxide production in diabetic mouse aorta through distinct pathways. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[64]  S. Kasif,et al.  Single-cell transcriptional networks in differentiating preadipocytes suggest drivers associated with tissue heterogeneity , 2020, Nature Communications.

[65]  L. Rui,et al.  Leptin receptor-expressing neuron Sh2b1 supports sympathetic nervous system and protects against obesity and metabolic disease , 2020, Nature Communications.

[66]  E. Kennelly,et al.  Structural diversity, bioactivities, and biosynthesis of natural diterpenoid alkaloids. , 2020, Natural product reports.

[67]  Ralitsa R Madsen,et al.  Cracking the context-specific PI3K signaling code , 2020, Science Signaling.

[68]  Cuihua Jiang,et al.  Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[69]  Li Tang,et al.  Anti-diabetic effects of a phenolic-rich extract from Hypericum attenuatum Choisy in KK-Ay mice mediated through AMPK /PI3K/Akt/GSK3β signaling and GLUT4, PPARγ, and PPARα expression , 2019, Journal of Functional Foods.

[70]  Qiaozhi Zhang,et al.  Phenolic compounds from coffee by-products modulate adipogenesis-related inflammation, mitochondrial dysfunction, and insulin resistance in adipocytes, via insulin/PI3K/AKT signaling pathways. , 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[71]  Yan Wang,et al.  Antidiabetic effects of pterostilbene through PI3K/Akt signal pathway in high fat diet and STZ-induced diabetic rats. , 2019, European journal of pharmacology.

[72]  Xiaojun Tang,et al.  The regulatory mechanisms of Yulangsan MHBFC reversing cardiac remodeling in rats based on eNOS-NO signaling pathway. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[73]  P. Jeppesen,et al.  Effect of Steviol Glycosides on Human Health with Emphasis on Type 2 Diabetic Biomarkers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2019, Nutrients.

[74]  E. Hirsch,et al.  p110γ deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicity , 2019, Proceedings of the National Academy of Sciences.

[75]  U. Smith,et al.  Reduced subcutaneous adipogenesis in human hypertrophic obesity is linked to senescent precursor cells , 2019, Nature Communications.

[76]  F. Bäckhed,et al.  Insulin-Driven PI3K-AKT Signaling in the Hepatocyte Is Mediated by Redundant PI3Kα and PI3Kβ Activities and Is Promoted by RAS. , 2019, Cell metabolism.

[77]  C. Juan,et al.  Visfatin Promotes Monocyte Adhesion by Upregulating ICAM-1 and VCAM-1 Expression in Endothelial Cells via Activation of p38-PI3K-Akt Signaling and Subsequent ROS Production and IKK/NF-κB Activation. , 2019, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

[78]  Yuning Chen,et al.  Carbenoxolone ameliorates insulin sensitivity in obese mice induced by high fat diet via regulating the IκB-α/NF-κB pathway and NLRP3 inflammasome. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[79]  C. Dani,et al.  Enhanced β-adrenergic signalling underlies an age-dependent beneficial metabolic effect of PI3K p110α inactivation in adipose tissue , 2019, Nature Communications.

[80]  Belén G. Sánchez,et al.  Capsaicin Targets Lipogenesis in HepG2 Cells Through AMPK Activation, AKT Inhibition and PPARs Regulation , 2019, International journal of molecular sciences.

[81]  Man Zhang,et al.  Glycyrrhetinic Acid Improves Insulin-Response Pathway by Regulating the Balance between the Ras/MAPK and PI3K/Akt Pathways , 2019, Nutrients.

[82]  Y. Abdel-Mottaleb,et al.  Raspberry ketone and Garcinia Cambogia rebalanced disrupted insulin resistance and leptin signaling in rats fed high fat fructose diet. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[83]  K. Copps,et al.  IL1R1 is required for celastrol’s leptin sensitization and anti-obesity effects , 2019, Nature Network Boston.

[84]  C. Sudlow,et al.  Body mass index and use and costs of primary care services among women aged 55–79 years in England: a cohort and linked data study , 2018, International Journal of Obesity.

[85]  Ralitsa R. Madsen,et al.  Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner , 2018, Proceedings of the National Academy of Sciences.

[86]  Milen I Georgiev,et al.  Causes and solutions to "globesity": The new fa(s)t alarming global epidemic. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[87]  Dean Y. Li,et al.  PI3Ka-Akt1-mediated Prdm4 induction in adipose tissue increases energy expenditure, inhibits weight gain, and improves insulin resistance in diet-induced obese mice , 2018, Cell Death & Disease.

[88]  H. Ashida,et al.  Epigallocatechin gallate induces GLUT4 translocation in skeletal muscle through both PI3K- and AMPK-dependent pathways. , 2018, Food & function.

[89]  Guihua Liu,et al.  The PI3K/AKT pathway in obesity and type 2 diabetes , 2018, International journal of biological sciences.

[90]  K. Cianflone,et al.  Anaphylatoxin C5a induces inflammation and reduces insulin sensitivity by activating TLR4/NF-kB/PI3K signaling pathway in 3T3-L1 adipocytes. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[91]  Laureline Berteloot,et al.  Targeted therapy in patients with PIK3CA-related overgrowth syndrome , 2018, Nature.

[92]  H. Hackl,et al.  Loss of ABHD15 Impairs the Anti-lipolytic Action of Insulin by Altering PDE3B Stability and Contributes to Insulin Resistance , 2018, Cell reports.

[93]  S. Dai,et al.  Ginsenoside Rb2 promotes glucose metabolism and attenuates fat accumulation via AKT-dependent mechanisms. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[94]  V. V. van Hinsbergh,et al.  Insulin Receptor Substrate 2 Controls Insulin-Mediated Vasoreactivity and Perivascular Adipose Tissue Function in Muscle , 2018, Front. Physiol..

[95]  K. Fujimori,et al.  Suppression of Fatty Acid and Triglyceride Synthesis by the Flavonoid Orientin through Decrease of C/EBPδ Expression and Inhibition of PI3K/Akt-FOXO1 Signaling in Adipocytes , 2018, Nutrients.

[96]  Huijun Sun,et al.  Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway , 2017, Pharmacological research.

[97]  J. Tan,et al.  Improvement of mitochondrial function by celastrol in palmitate-treated C2C12 myotubes via activation of PI3K-Akt signaling pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[98]  Juan Chen,et al.  Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats , 2017, Front. Pharmacol..

[99]  V. Beral,et al.  Hospital costs in relation to body-mass index in 1·1 million women in England: a prospective cohort study , 2017, The Lancet. Public health.

[100]  H. Aisa,et al.  Anti-diabetic effect of three new norditerpenoid alkaloids in vitro and potential mechanism via PI3K/Akt signaling pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[101]  Haixia Chen,et al.  Network Pharmacology Studies on the Bioactive Compounds and Action Mechanisms of Natural Products for the Treatment of Diabetes Mellitus: A Review , 2017, Front. Pharmacol..

[102]  G. Hotamışlıgil.  Inflammation, metaflammation and immunometabolic disorders , 2017, Nature.

[103]  Qiren Huang,et al.  Epigallocatechin‐3‐gallate inhibits adipogenesis through down‐regulation of PPAR&ggr; and FAS expression mediated by PI3K‐AKT signaling in 3T3‐L1 cells , 2017, European journal of pharmacology.

[104]  F. Ornellas,et al.  The insulin-signaling pathway of the pancreatic islet is impaired in adult mice offspring of mothers fed a high-fat diet. , 2016, Nutrition.

[105]  H. Khan,et al.  Plant Alkaloids as Antiplatelet Agent: Drugs of the Future in the Light of Recent Developments , 2016, Front. Pharmacol..

[106]  Kyu-Tae Chang,et al.  Isoliquiritigenin impairs insulin signaling and adipocyte differentiation through the inhibition of protein-tyrosine phosphatase 1B oxidation in 3T3-L1 preadipocytes. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[107]  C. Calaminus,et al.  PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome , 2016, Proceedings of the National Academy of Sciences.

[108]  Xiaoke Zheng,et al.  The Mechanism by Which Amentoflavone Improves Insulin Resistance in HepG2 Cells , 2016, Molecules.

[109]  T. Takenawa,et al.  Regulation of insulin signaling in skeletal muscle by PIP3 phosphatase, SKIP, and endoplasmic reticulum molecular chaperone glucose-regulated protein 78. , 2015, Biochimica et biophysica acta.

[110]  J. Backer,et al.  PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling , 2015, Nature Communications.

[111]  R. de Cabo,et al.  Pharmacological inhibition of PI3K reduces adiposity and metabolic syndrome in obese mice and rhesus monkeys. , 2015, Cell metabolism.

[112]  M. Rodeheffer,et al.  Rapid Depot-Specific Activation of Adipocyte Precursor Cells at the Onset of Obesity , 2015, Nature Cell Biology.

[113]  N. Al-Dhabi,et al.  Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway. , 2014, European journal of pharmacology.

[114]  A. Vercelli,et al.  Combined inhibition of PI3Kβ and PI3Kγ reduces fat mass by enhancing α-MSH–dependent sympathetic drive , 2014, Science Signaling.

[115]  A. Kiger,et al.  Classes of phosphoinositide 3-kinases at a glance , 2014, Journal of Cell Science.

[116]  J. Holst,et al.  Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[117]  D. Klemm,et al.  Adipose tissue insulin sensitivity and macrophage recruitment , 2013, Adipocyte.

[118]  D. Bentrem,et al.  PI3K/AKT Signaling Is Essential for Communication between Tissue-Infiltrating Mast Cells, Macrophages, and Epithelial Cells in Colitis-Induced Cancer , 2013, Clinical Cancer Research.

[119]  B. Vanhaesebroeck,et al.  Long-term p110α PI3K inactivation exerts a beneficial effect on metabolism , 2013, EMBO molecular medicine.

[120]  Liwu Li,et al.  Molecular Mechanism Responsible for the Priming of Macrophage Activation* , 2012, The Journal of Biological Chemistry.

[121]  J. Levy,et al.  PTEN mutations as a cause of constitutive insulin sensitivity and obesity. , 2012, The New England journal of medicine.

[122]  S. Mukhopadhyay,et al.  Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance , 2012, Nature Medicine.

[123]  P. Pandolfi,et al.  Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic State , 2012, Cell.

[124]  A. Efeyan,et al.  Pten positively regulates brown adipose function, energy expenditure, and longevity. , 2012, Cell metabolism.

[125]  J. Olefsky,et al.  The cellular and signaling networks linking the immune system and metabolism in disease , 2012, Nature Medicine.

[126]  J. Montani,et al.  PI3Kγ within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance , 2011, Proceedings of the National Academy of Sciences.

[127]  Takehiko Sasaki,et al.  Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance , 2011, Proceedings of the National Academy of Sciences.

[128]  B. Lowell,et al.  Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. , 2008, The Journal of clinical investigation.

[129]  H. Münzberg,et al.  Enhanced leptin-stimulated Pi3k activation in the CNS promotes white adipose tissue transdifferentiation. , 2007, Cell metabolism.

[130]  C. Kahn,et al.  Phosphoinositide 3-kinase regulatory subunit p85α suppresses insulin action via positive regulation of PTEN , 2006, Proceedings of the National Academy of Sciences.

[131]  Robbie Loewith,et al.  A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling , 2006, Cell.

[132]  K. Okkenhaug,et al.  Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation , 2006, Nature.

[133]  K. Wellen,et al.  Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.

[134]  G. Barsh,et al.  PI3K integrates the action of insulin and leptin on hypothalamic neurons. , 2005, The Journal of clinical investigation.

[135]  E. Prigmore,et al.  Requirement for PI 3-kinase γ in macrophage migration to MCP-1 and CSF-1 , 2003 .

[136]  S. Koyasu.  The role of PI3K in immune cells , 2003, Nature Immunology.

[137]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[138]  M. White,et al.  Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* , 2002, The Journal of Biological Chemistry.

[139]  M. Schwartz,et al.  Intracellular signalling: Key enzyme in leptin-induced anorexia , 2001, Nature.

[140]  Silvano Sozzani,et al.  Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation , 2000 .

[141]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[142]  E. Prossnitz,et al.  Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. , 1995, Journal of immunology.

[143]  T. Okada,et al.  Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. , 1994, The Journal of biological chemistry.

[144]  Feng Zhang,et al.  Dihydroartemisinin inhibits ER stress-mediated mitochondrial pathway to attenuate hepatocyte lipoapoptosis via blocking the activation of the PI3K/Akt pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[145]  J. Holst,et al.  Antihyperglycemic effects of stevioside in type 2 diabetic subjects. , 2004, Metabolism: clinical and experimental.

[146]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.